Georgieva Maya, Mateev Emilio, Valkova Iva, Kuteva Hristina, Tzankova Diana, Stefanova Denitsa, Yordanov Yordan, Lybomirova Karolina, Zlatkov Alexander, Tzankova Virginia, Kondeva-Burdina Magdalena
Department Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Department Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Molecules. 2024 Sep 12;29(18):4338. doi: 10.3390/molecules29184338.
Neurodegenerative diseases such as Parkinson's and Alzheimer's continue to be some of the most significant challenges in modern medicine. Recent research related to the molecular mechanisms of parkinsonism has opened up new approaches to antiparkinsonian therapy. In response to this, we present the evaluation of the potential neuroprotective and MAOA/MAOB inhibitory effects of newly synthesized hydrazones, containing a pyrrole moiety in the carboxyl fragment of the structure. The substances were studied on different brain subcellular fractions, including rat brain synaptosomes, mitochondria, and microsomes. The single application of 50 µM of each compound to the subcellular fractions showed that all substances exhibit a weak neurotoxic effect, with , , and being the least neurotoxic representatives. The corresponding neuroprotective and antioxidant effects were also evaluated in different injury models on subcellular fractions, single out , , and as the most prominent derivatives. A 1 µM concentration of each molecule from the series was also studied for potential MAOA/MAOB inhibitory effects. The results revealed a lack of MAOA activity for all evaluated structures and the appearance of MAOB effects, with compounds , , and showing effects similar to those of selegiline. The best MAOB selectivity index (>204) was determined for and , distinguishing these two representatives as the most promising molecules for further studies as potential selective MAOB inhibitors. The performed molecular docking simulations defined the appearance of selective MAOB inhibitory effects based on the interaction of the tested molecules with Tyr398, which is one of the components of the aromatic cage of MAOB and participated in π-π stabilization with the aromatic pyrrole ring. The preliminary PAMPA testing indicated that in relation to the blood-brain barrier (BBB) permeability, the tested pyrrole-based hydrazones may be considered as high permeable, except for and , which were established to be permeable in the medium range with -logP of 5.268 and 5.714, respectively, compared to the applied references.
帕金森病和阿尔茨海默病等神经退行性疾病仍然是现代医学面临的一些最重大挑战。最近关于帕金森症分子机制的研究为抗帕金森病治疗开辟了新途径。对此,我们展示了对新合成的腙的潜在神经保护和单胺氧化酶A/单胺氧化酶B抑制作用的评估,这些腙在结构的羧基片段中含有吡咯部分。在不同的脑亚细胞组分上对这些物质进行了研究,包括大鼠脑突触体、线粒体和微粒体。将每种化合物50µM单次应用于亚细胞组分表明,所有物质均表现出较弱的神经毒性作用,其中[具体物质1]、[具体物质2]和[具体物质3]是神经毒性最小的代表。在不同的亚细胞组分损伤模型中也评估了相应的神经保护和抗氧化作用,选出[具体物质4]、[具体物质5]和[具体物质6]作为最突出的衍生物。还研究了该系列中每种分子1µM浓度的潜在单胺氧化酶A/单胺氧化酶B抑制作用。结果显示,所有评估结构均无单胺氧化酶A活性,出现了单胺氧化酶B效应,化合物[具体物质7]、[具体物质8]和[具体物质9]显示出与司来吉兰相似得效应。确定[具体物质10]和[具体物质11]的最佳单胺氧化酶B选择性指数(>204),将这两种代表物区分出来,作为作为潜在的选择性单胺氧化酶B抑制剂进行进一步研究的最有前景的分子。所进行的分子对接模拟确定了基于测试分子与Tyr398的相互作用而出现的选择性单胺氧化酶B抑制作用,Tyr398是单胺氧化酶B芳香笼的组成部分之一,并与芳香吡咯环参与π-π稳定作用。初步的平行人工膜渗透实验(PAMPA)测试表明,就血脑屏障(BBB)通透性而言,所测试的基于吡咯的腙除了[具体物质12]和[具体物质13]外,可被视为高通透性,与应用的参比物相比,[具体物质12]和[具体物质13]在中等范围内具有通透性,其-logP分别为5.268和5.714。